Company Filing History:
Years Active: 2018-2021
Title: Innovations by Atsushi Narita
Introduction
Atsushi Narita is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the development of cytotoxicity-inducing molecules. With a total of 3 patents to his name, Narita's work is paving the way for advancements in cancer treatment.
Latest Patents
One of Narita's latest patents focuses on a cytotoxicity-inducing therapeutic agent. This innovation involves replacing the antigen-binding domain to create novel polypeptide complexes that maintain BiTE's strong anti-tumor activity and excellent safety properties. These complexes also exhibit a long half-life in blood and can damage various target cells. Another significant patent involves multi-specific antigen-binding molecules that maintain excellent cellular cytotoxicity and high stability. These molecules comprise a domain containing an antibody variable region with glypican 3-binding activity and another domain with T-cell receptor complex-binding activity. The strong cytotoxicity of these molecules against cells expressing glypican 3 allows for the potential development of pharmaceutical compositions aimed at treating or preventing various cancers.
Career Highlights
Atsushi Narita is currently associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has been instrumental in advancing therapeutic innovations that address critical health challenges.
Collaborations
Narita has collaborated with notable colleagues, including Junichi Nezu and Takahiro Ishiguro. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapeutic solutions.
Conclusion
Atsushi Narita's contributions to the field of therapeutic agents highlight his commitment to advancing cancer treatment through innovative inventions. His work continues to inspire future developments in the medical field.